Inhibition of Prostaglandin Synthesis and Its Effect on Uterine Activity During Established Premature Labor in Sheep

Abstract

Objective: Continuous infusion of the selective prostaglandin synthase type-2 inhibitor nimesulide, together with the oxytocin receptor antagonist atosiban, inhibits glucocorticoid induction of labor in sheep. We evaluated the effectiveness of this treatment commencing after the onset of premature labor when prostaglandin concentrations are already significantly elevated.

Methods: Premature labor was induced in chronically cannulated fetuses by constant fetal dexamethasone infusion. After the onset of active labor in each ewe, defined as uterine electromyographic (EMG) activity twice basal levels, ewes received combined nimesulide and atosiban (20.0 and 4.12 mg/kg per day, respectively; n = 6) or vehicle (n-methyl-2-pyrrolidone and saline each 1 mL/hour; n = 4) infusions for 48 hours. Maternal and fetal plasma PGFM (13, 14-dihydro-15-keto PGF_2α, the stable metabolite of prostaglandin (PG) F_2α) and PGE₂ concentrations were measured before, during, and after infusions.

Results: Four nimesulide- and atosiban-treated ewes successfully completed the 48-hour infusion period with no deliveries occurring during inhibitor treatment, or up to 6 hours after inhibitor treatment. Delivery was delayed in two other ewes, compared with control animals. Uterine EMG activity in nimesulide- and atosiban-treated ewes (n = 4) was significantly reduced during the 48-hour inhibitor treatmenmt period. Maternal and fetal prostaglandin concentrations were significantly decreased in inhibitor-treated ewes during and after the infusions.

Conclusions: The combination of nimesulide and atosiban treatment for 48 hours successfully inhibited the progression of active premature labor to delivery. This study further supports the potential value of this treatment regime for the inhibition of premature labor.

Keywords

Prostaglandins nimesulide atosiban preterm labor

Get full access to this article

View all access options for this article.

References

1. Challis JRG , Lye SJ . Parturition. In: Knobil E , Neill JD , eds. The physiology of reproduction. 2nd ed. Raven Press: New York, 1994: 985-1032.

2. Rice Ge . Labour: A process dependent upon prostaglandin G/H synthase. Repro Fertil Develop 1990;2:523-533.

3. Smith WL , Garavito M , Dewitt D . Prostaglandin endoperoxide H synthase (cyclooxygenases) -1 and -2. J Biol Chem 1996;271:33157-33160.

4. Hirst JJ , Teixeira F , Zakar T , Olson D . Prostaglandin H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reprod Fertil Develop 1995;7:633-637.

5. McLaren WJ , Young IR , Wong MH , Rice GE . Expression of prostaglandin G/H synthase-1 and -2 in ovine amnion and placenta following glucocorticoid-induced labour onset. J Endocrinol 1996;151:125-135.

6. Fuchs AR , Fuchs F , Husslein P , Soloff MS . Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734-741.

7. Anderson LF , Lyndrup J , Åkerlund M , Melin P . Oxytocin receptor blockage: A new principle in the treatment of preterm labour? Am J Perinat 1989;6:196-199.

8. Burgess KM , Ralph MM , Jenkin G , Thorburn GD . Effect of oxytocin and estradiol on uterine prostaglandin release in non-pregnant and early pregnant ewes. Biol Reprod 1990;42:822-833.

9. Keirse MJNC . Inhibitors of prostaglandin synthesis for treatment of preterm labour. In: Drife JO , Calder AA , eds. Prostaglandins and the uterus. London: Springer-Verlag, 1992:277-293.

10.

10. Moise KJ . Effect of advancing gestational age on the frequency of the fetal ductal constriction in association with maternal indomethacin usage. Am J Obstet Gynecol 1983; 168:1350-1353.

11.

11. Norton ME , Merrill J , Cooper BA , et al. Neonatal complications after administration of indomethacin for preterm labour. N Engl J Med 1993;329:1062-1067.

12.

12. Guerguerian AM , Hardy P , Bhattacharya M , et al. Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs. Am J Obstet Gynecol 1998;179:1618-1628.

13.

13. Steer P , Flint C . ABC of labour care: Preterm labour and premature rupture of membranes. BMJ 1999;318:1059-1062.

14.

14. Keirse M . New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 1995;173:618-628.

15.

15. Grigsby PL , Poore KR , Hirst JJ , Jenkin G . Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type-2 inhibitor and an oxytocin receptor antagonist. Am J Obstet Gynecol 2000;183:649-657.

16.

16. Melin P . Oxytocin antagonists in preterm labour and delivery. Clin Obstet Gynecol 1993;7:577-600.

17.

17. Moutquin JM , Sherman D , Cohen H , et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: A multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191-1199.

18.

18. Akerlund M , Stromberg P , Hauksson A , et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynecol 1987;94:1040-1044.

19.

19. Amon, E , Midkiff C , Winn H , Holcomb W , Shumway J , Artal R . Tocolysis with advanced cervical dilation. Obstet Gynecol 2000;95:358-362.

20.

20. Bernareggi A . Clinical pharmacokinetics of nimesulide. Clin Pharmaol 1998;35:247-274.

21.

21. Goodwin TM , Millar L . North L , Abrams LS , Weglein RC , Holland ML . The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. Am J Obstet Gynecol 1995;173:913-917.

22.

22. Fowden AL , Harding R , Ralph MM , Thorburn GD . The nutritional regulation of plasma prostaglandin E concentrations in the fetus and pregnant ewe during late gestation. J Physiol 1987;394:1-12.

23.

23. Rice GE , Jenkin G , Throburn GD . Comparison of particle-associated progesterone and oxytocin in the ovine corpus luteum. J Endocrinol 1986;108:109-116.

24.

24. Nathanielsz PW , Honnebier MBOM . Myometrial function. In: Drife JO , Calder AA , eds. Prostaglandins and the uterus. New York: Springer-Verlag, 1992:161-177.

25.

25. Mijovic JE , Zakar T , Nairn TK , Olson DM . Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. J Clin Endocrinol Metab 1998;83:1358-1367.

26.

26. Reece J , Paria BC , Brown N , Zhao X , Morrow JD , Dey SK . Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci U S A 2000;97:9759-9764.

27.

27. Coleman RA , Kennedy I , Humphrey PPA , Levey GP , Lumley P . Prostanoids and their receptors. In: Hansch C , Sammes PG , Taylor JB , eds. Comprehensive medical chemistry. Oxford: Pergamon Press, 1990:643-714.

28.

28. Adelantado JM , Lopez BA , Turnbull AC . Topographical distribution of prostaglandin E receptors in human myometrium. Br J Obstet Gynaecol 1988;95:348-353.

29.

29. Ma XH , Wu WX , Nathanielsz PW . Differential regulation of prostaglandin EP and FP receptors in pregnant sheep myometrium and endometrium during spontaneous term labor. Biol Reprod 1999;61:1281-1286.

30.

30. Baguma-Nibasheka M , Nathanielsz PW . In vivo administration of nimesulide, a selective PGHS-2 inhibitor, increases in vitro myometrial sensitivity to prostaglandins while lowering sensitivity to oxytocin. J Soc Gynecol Investig 1998;5:296-299.

31.

31. Edwin SS , Romero RJ , Munoz H , Branch DW , Mitchell MD . 5-hydroxyeicosatetraenoic acid and human parturition. Prostaglandins 1996;51:403-412.

32.

32. Bennett PR , Elder MG , Myatt L . The effects of lipoxygenase metabolites of arachidonic acid on human myometrial contractility. Prostaglandins 1987;33:837-844.

33.

33. Olson DM , Mijovic JE , Zaragoza DB , Cook JL . Prostaglandin endoperoxide H synthase type 1 and 2 messenger ribonucleic acid in human fetal tissues throughout gestation and in the newborn infant. Am J Obstet Gynecol 2001;184:169-174.

34.

34. Grieg PC , Massmann A , Demarest KT , Weglein RC , Holland ML , Figueroa JP . Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late gestation pregnant sheep. Am J Obstet Gynecol 1993;169:897-902.

35.

35. Jack PM , Nathanielsz PW , Thomas AL , Steven DH . Ultrastructural changes in the placenta of the ewe following foetal infusion of cortisol. Q J Exp Physiol Cogn Med Sci 1975;60:171-179.

36.

36. Ludmir J , Sehdev H . Anatomy and physiology of the uterine cervix. J Clin Obstet Gynecol 2000;43:433-439.

37.

37. Bukowski R , MacKay L , Fittkow C , Shi L , Saade GR , Garfield RE . Inhibition of cervical ripening by local application of cyclooxygenase 2 inhibitor. Am J Obstet Gynecol 2001;184:1374-1379.